City of Hope opens first U.S. multicenter clinical trial for robotic single-port mastectomies for breast cancer patients
Trial results could eventually lead to less invasive, significantly improved breast surgery
2023-10-03
(Press-News.org) LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, is opening a multicenter clinical trial to evaluate the efficacy of robotic-assisted, single-incision mastectomies. The minimally invasive procedure, which preserves the nipple and leaves only a small hidden scar on the side of the body, could potentially lead to significant improvements for breast surgery.
“City of Hope is once again taking the lead in investigating innovations, treatments and therapies that are making big leaps forward for patients with cancer. We’re participating in what we believe is a groundbreaking clinical trial that we hope will simultaneously result in the best possible aesthetic outcome,” said Jennifer Tseng, M.D., medical director of breast surgery at City of Hope Orange County and principal investigator on the clinical trial.
The study is open to patients in the early stages of breast cancer. Participants will be part of a comparative and randomized trial, meaning half will receive traditional open nipple-sparing surgery and others will undergo the single-incision robotic procedure.
“City of Hope offers the most advanced breast cancer treatments,” said Jamie Rand, M.D., a breast cancer surgeon at City of Hope and subinvestigator on the clinical trial. “This new clinical trial holds a lot of promise. We are excited to offer this state-of-the-art technology to our patients with the goal of improving outcomes and quality of life.”
For the robotic-assisted procedure, surgeons will use the single-port da Vinci SP robotic-assisted surgical system, manufactured by Intuitive, the study sponsor.
Surgeons at City of Hope, a leader in robotic surgery, have performed more than 16,000 nonmastectomy robotic procedures. They are frequently requested to train others on using the da Vinci SP, which the Food and Drug Administration has cleared in the U.S. for urology and transoral otolaryngology procedures.
“We are pleased to add this study to the more than 800 clinical trials offered at City of Hope each year,” said Yuman Fong, M.D., the Sangiacomo Family Chair in Surgical Oncology at City of Hope and director of its Center for Surgical Innovation. “This procedure could be a breakthrough for breast cancer surgery and, true to our reputation, we want to provide the latest surgical and medical options for our patients.”
More information about this clinical trial can be found at CityofHope.org/research/clinical-trials or clinicaltrials.gov. People interested in City of Hope’s advanced services for breast cancer care can call 800-826-4673.
# # #
About City of Hope
City of Hope's mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and treatment facilities in Atlanta, Chicago and Phoenix. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram and LinkedIn.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-10-03
Oak Brook, IL – A Special Issue of SLAS Discovery, Emerging Drug Discovery Ecosystems, is new for September. Volume 28, Issue 6 features three perspectives, one original research article and one protocol that align with the Virginia Drug Discovery Consortium (VaDDC) and its efforts to enhance and promote drug discovery and development in the Commonwealth of Virginia.
Perspective
An acute respiratory distress syndrome drug development collaboration stimulated by the Virginia Drug Discovery Consortium
This ...
2023-10-03
Communities with more socioeconomic vulnerability experience longer-duration power outages than more advantaged communities, according to a study. Research has shown that environmental disasters hit economically and socially vulnerable communities hardest. Scott Ganz and colleagues assessed the unequal impacts caused by the procedures electric utilities follow to restore power to customers after extreme-weather related outages. Using data from eight Atlantic hurricanes that made landfall between January 2017 and October 2020, which knocked out power for a total of over 15 million customers in 588 counties in the Southeast, the authors find ...
2023-10-03
The Genomics Platform at the Broad Institute of MIT and Harvard has been one of the world’s leading academic genome sequencing centers since the days of the Human Genome Project. For the last decade, these services have included clinical sequencing and other molecular assays through its wholly-owned subsidiary, the Clinical Research Sequencing Platform.
Now renamed Broad Clinical Labs (BCL), the lab is poised to further accelerate the power of ’omics technologies in clinical research, screening, and diagnostics.
BCL supports large-scale projects for which results need to be generated under a clinical quality system, such as analyses for clinical trials, biobank profiling, ...
2023-10-03
UMass Amherst researchers have pushed forward the boundaries of biomedical engineering one hundredfold with a new method for DNA detection with unprecedented sensitivity.
“DNA detection is in the center of bioengineering,” says Jinglei Ping, lead author of the paper that appeared in Proceedings of the National Academy of Sciences. Ping is an assistant professor of mechanical and industrial engineering, an adjunct assistant professor in biomedical engineering and affiliated with the Center for Personalized Health Monitoring of the Institute for Applied Life Sciences. “Everyone ...
2023-10-03
An individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an international team of researchers has warned.
Even people who do not develop the condition until later in life – with a diagnosis at age 50 years – could see their life expectancy fall by up to six years, an analysis of data from 19 high-income countries found.
The researchers say the findings, published in The Lancet Diabetes & Endocrinology, highlight the urgent need to ...
2023-10-03
Watching a loved one suffer the slow decline of dementia is hard enough.
But trying to find care for them that’s high-quality, safe, available and affordable is nearly as difficult, as millions of American families have found out the hard way in recent years.
That lack of options stems from a combination of workforce shortages, payment policies and a lack of consistency in dementia care delivery and regulation, according to experts from the University of Michigan and the University of California, San Francisco and their colleagues.
Now, fueled by new five-year funding expected to total $81 million from the NIH’s National Institute on Aging or ...
2023-10-03
New research by the psychologists Lucía Vicente and Helena Matute from Deusto University in Bilbao, Spain, provides evidence that people can inherit artificial intelligence biases (systematic errors in AI outputs) in their decisions.
The astonishing results achieved by artificial intelligence systems, which can, for example, hold a conversation as a human does, have given this technology an image of high reliability. More and more professional fields are implementing AI-based tools to support the decision-making of specialists to minimise errors in their decisions. However, this technology is not without risks due to biases in AI results. ...
2023-10-03
The decision to reach for a sugary beverage is heavily influenced by where you live, Friedman School of Nutrition Science and Policy researchers report in a new study published October 3 in the journal Nature Communications. While an analysis of the Global Dietary Database for the years 1990, 2005, and 2018 found overall consumption of sweetened drinks increased—by nearly 16% worldwide over the 28-year period studied—regional intake widely varied.
Sugary drinks are a public health concern because they have been widely associated ...
2023-10-03
Australian researchers have developed a molecular-sized, more efficient version of a widely used electronic sensor, in a breakthrough that could bring widespread benefits.
Piezoresistors are commonly used to detect vibrations in electronics and automobiles, such as in smart phones for counting steps, and for airbag deployment in cars. They are also used in medical devices such as implantable pressure sensors, as well as in aviation and space travel.
In a nationwide initiative, researchers led by Dr Nadim Darwish from Curtin University, Professor Jeffrey ...
2023-10-03
Key takeaways
Rising temperatures will cut the number of days when conditions favor prescribed fires by 17% on average across the Western U.S., mostly in spring and summer.
Winter, however, will see a net 4% increase in the number of favorable days.
Implementing controlled burns in the West will require changes to policy and the availability of firefighters.
Prescribed fires, sometimes called controlled burns, are one of the most common tools for preventing catastrophic wildfires in the Western United States. Lit by highly trained firefighters, they help clear away excess dry plant matter that might otherwise ...
LAST 30 PRESS RELEASES:
[Press-News.org] City of Hope opens first U.S. multicenter clinical trial for robotic single-port mastectomies for breast cancer patients
Trial results could eventually lead to less invasive, significantly improved breast surgery
